1. Home
  2. MGYR vs EQ Comparison

MGYR vs EQ Comparison

Compare MGYR & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magyar Bancorp Inc.

MGYR

Magyar Bancorp Inc.

HOLD

Current Price

$17.40

Market Cap

112.7M

Sector

Finance

ML Signal

HOLD

EQ

Equillium Inc.

HOLD

Current Price

$3.08

Market Cap

129.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGYR
EQ
Founded
1922
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.7M
129.0M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
MGYR
EQ
Price
$17.40
$3.08
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.00
AVG Volume (30 Days)
2.1K
401.2K
Earning Date
04-23-2026
05-25-2026
Dividend Yield
2.30%
N/A
EPS Growth
26.83
N/A
EPS
0.98
N/A
Revenue
N/A
$41,095,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.61
$0.29
52 Week High
$20.00
$3.10

Technical Indicators

Market Signals
Indicator
MGYR
EQ
Relative Strength Index (RSI) 47.82 70.41
Support Level $17.00 $1.53
Resistance Level $17.72 N/A
Average True Range (ATR) 0.15 0.30
MACD -0.03 0.09
Stochastic Oscillator 62.64 96.28

Price Performance

Historical Comparison
MGYR
EQ

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: